MICRO-X LIMITED — Regulatory Filings 2021

May 16, 2021

==> picture [159 x 46] intentionally omitted <==

Micro-X Limited, ABN 21 153 273 735

MICRO-X PRESENTS AT AUSMED TECH 2021 CONFERENCE

Virtual Conference at 1:30pm AEDT on 17 May 2021

Adelaide, Australia, 17 May 2021: Australian hi-tech company Micro-X Ltd (ASX:MX1) ( Micro-X or the Company ), a leader in cold cathode x-ray technology for the healthcare and security markets globally, announces that the Company’s CEO and Managing Director, Peter Rowland will be presenting at the 2021 AusMedtech conference on 17 May 2021.

Mr Rowland will participate on a panel in the session ‘ Australia’s manufacturing makeover in the wake of COVID-19 ’. The session will cover the part that manufacturing plays in the commercialisation pathway of medical devices as well as trends in manufacturing supply chains in light of the COVID-19 pandemic and the impact of government policy for the sector.

AusMedtech is Australia’s premier medical technology conference bringing together stakeholders in the Australian and international devices and diagnostics sector. This virtual event will host over 65 speakers and 22 sessions across 5 days. To register to attend follow the link at: https://www.ausmedtech.com.au/registration

This announcement is approved by Kingsley Hall, Company Secretary of Micro-X.

– ENDS –

About Micro-X

Micro-X Limited (the Company ) is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. Micro-X has two mobile digital medical x-ray systems being sold commercially for diagnostic healthcare applications and Micro-X medical products are now in operation in 14 countries around the world.

Micro-X has a portfolio of innovative products in development, including the MBI for imaging Improvised Explosive Devices in security, defence and counter-terrorism applications; a next-generation self-service X-Ray Airport Checkpoint Portal with an integrated body scanner; and a lightweight brain CT imager for early stroke diagnosis in ambulances. Micro-X has its core R&D, engineering and production capability in Adelaide, Australia with a fully in-sourced CNT tube manufacturing line and approximately 95% Australian locally manufactured content.

CONTACTS

Micro-X Limited	Investor Enquiries
Peter Rowland Managing Director Tel: +61 8 7099 3966 E:admin@micro-x.com	David Allen / John Granger Hawkesbury Partners Tel: +61 2 9103 9494 E:dallen@hawkesburypartners.com jgranger@hawkesburypartners.com

Micro-X Limited, 1284 South Road, Tonsley, South Australia, 5042, AUSTRALIA

www.micro-x.com